1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor : The AGITG ALT-GIST intergroup randomized phase II trial: Clinical Studies
Yip, Desmond ; Zalcberg, John ; Blay, Jean Yves ; Eriksson, Mikael LU
; Espinoza, David
; Price, Timothy
; Marreaud, Sandrine
; Italiano, Antoine
; Steeghs, Neeltje
and Boye, Kjetil
, et al.
(2025)
In British Journal of Cancer
132(10).
p.897-904
- Contribution to journal › Article
- 2024
-
Mark
Germline copy number variants and endometrial cancer risk
- Contribution to journal › Article